113 related articles for article (PubMed ID: 9873368)
21. Three-dimensional molecular shape analysis-quantitative structure-activity relationship of a series of cholecystokinin-A receptor antagonists.
Tokarski JS; Hopfinger AJ
J Med Chem; 1994 Oct; 37(21):3639-54. PubMed ID: 7932591
[TBL] [Abstract][Full Text] [Related]
22. Differentiation of central and peripheral cholecystokinin receptors by new glutaramic acid derivatives with cholecystokinin-antagonistic activity.
Makovec F; Bani M; Chisté R; Revel L; Rovati LC; Rovati LA
Arzneimittelforschung; 1986; 36(1):98-102. PubMed ID: 3006713
[TBL] [Abstract][Full Text] [Related]
23. Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity (II): Optimization of the C3 amino substituent.
Hirst GC; Aquino C; Birkemo L; Croom DK; Dezube M; Dougherty RW; Ervin GN; Grizzle MK; Henke B; James MK; Johnson MF; Momtahen T; Queen KL; Sherrill RG; Szewczyk J; Willson TM; Sugg EE
J Med Chem; 1996 Dec; 39(26):5236-45. PubMed ID: 8978852
[TBL] [Abstract][Full Text] [Related]
24. (3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist.
Semple G; Ryder H; Rooker DP; Batt AR; Kendrick DA; Szelke M; Ohta M; Satoh M; Nishida A; Akuzawa S; Miyata K
J Med Chem; 1997 Jan; 40(3):331-41. PubMed ID: 9022799
[TBL] [Abstract][Full Text] [Related]
25. 5-(Tryptophyl)amino-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based potent and selective CCK(1)receptor antagonists: structure-activity relationship studies on the substituent at N2-position.
Bartolomé-Nebreda JM; Patiño-Molina R; Martín-Martínez M; Gómez-Monterrey I; García-López MT; González-Muñiz R; Cenarruzabeitia E; Latorre M; Del Río J; Herranz R
J Med Chem; 2001 Jun; 44(13):2219-28. PubMed ID: 11405658
[TBL] [Abstract][Full Text] [Related]
26. Conformationally restricted analogues of the potent CCK-B antagonist CI-988.
Higginbottom M; Hill DR; Horwell DC; Mostafai E; Suman-Chauhan N; Roberts E
Bioorg Med Chem; 1993 Sep; 1(3):209-17. PubMed ID: 8081854
[TBL] [Abstract][Full Text] [Related]
27. Biological activity of analogues of YM022. Novel (3-amino substituted phenyl)urea derivatives of 1,4-benzodiazepin-2-one as gastrin/cholecystokinin-B receptor antagonists.
Satoh M; Okamoto Y; Koshio H; Ohta M; Nishida A; Akuzawa S; Miyata K; Mase T; Semple G
Chem Pharm Bull (Tokyo); 1996 Jul; 44(7):1412-4. PubMed ID: 8706146
[TBL] [Abstract][Full Text] [Related]
28. Novel 1,5-benzodiazepines as CCK-B ligands. Effect of aryl-carbamic substituents at the C-3 position together with halogen substitution on the benzo-fused ring.
Tranquillini ME; Cassarà PG; Corsi M; Curotto G; Donati D; Finizia G; Pentassuglia G; Polinelli S; Tarzia G; Ursini A; van Amsterdam FT
Arch Pharm (Weinheim); 1997 Nov; 330(11):353-7. PubMed ID: 9431027
[No Abstract] [Full Text] [Related]
29. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
[TBL] [Abstract][Full Text] [Related]
30. 1,4-Benzodiazepine peripheral cholecystokinin (CCK-A) receptor agonists.
Sherrill RG; Berman JM; Birkemo L; Croom DK; Dezube M; Ervin GN; Grizzle MK; James MK; Johnson MF; Queen KL; Rimele TJ; Vanmiddlesworth F; Sugg EE
Bioorg Med Chem Lett; 2001 May; 11(9):1145-8. PubMed ID: 11354363
[TBL] [Abstract][Full Text] [Related]
31. Biological effects of newly synthesized cholecystokinin analogs.
Verspohl EJ; LaMura M
Horm Res; 2000; 53(4):177-84. PubMed ID: 11044801
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
Nishida A; Miyata K; Tsutsumi R; Yuki H; Akuzawa S; Kobayashi A; Kamato T; Ito H; Yamano M; Katuyama Y
J Pharmacol Exp Ther; 1994 May; 269(2):725-31. PubMed ID: 7910212
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and structure-activity relationships of dual histamine H2 and gastrin receptor antagonists with modified benzodiazepine skeletons.
Kawanishi Y; Ishihara S; Tsushima T; Seno K; Hagishita S; Ishikawa M; Ishihara Y
Bioorg Med Chem; 1997 Jul; 5(7):1411-23. PubMed ID: 9377101
[TBL] [Abstract][Full Text] [Related]
34. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
Zhou W; Povoski SP; Bell RH
J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
[TBL] [Abstract][Full Text] [Related]
35. 5-Phenyl-3-ureidobenzazepin-2-ones as cholecystokinin-B receptor antagonists.
Lowe JA; Hageman DL; Drozda SE; McLean S; Bryce DK; Crawford RT; Zorn S; Morrone J; Bordner J
J Med Chem; 1994 Oct; 37(22):3789-811. PubMed ID: 7966138
[TBL] [Abstract][Full Text] [Related]
36. Antagonistic effect of YM022, an antiulcer agent in rats, on human cholecystokinin (CCK)B/gastrin receptor.
Koizumi T; Saita Y; Miyake A; Nishida A; Yazawa H; Honda K
Jpn J Pharmacol; 1996 Aug; 71(4):307-13. PubMed ID: 8886928
[TBL] [Abstract][Full Text] [Related]
37. Peptide/benzodiazepine hybrids as ligands of CCK(A) and CCK(B) receptors.
Escherich A; Lutz J; Escrieut C; Fourmy D; van Neuren AS; Müller G; Schafferhans A; Klebe G; Moroder L
Biopolymers; 2000-2001; 56(2):55-76. PubMed ID: 11592053
[TBL] [Abstract][Full Text] [Related]
38. Cholecystokinin B antagonists. Synthesis and quantitative structure-activity relationships of a series of C-terminal analogues of CI-988.
Augelli-Szafran CE; Horwell DC; Kneen C; Ortwine DF; Pritchard MC; Purchase TS; Roth BD; Trivedi BK; Hill D; Suman-Chauhan N; Webdale L
Bioorg Med Chem; 1996 Oct; 4(10):1733-45. PubMed ID: 8931944
[TBL] [Abstract][Full Text] [Related]
39. CCK(2) receptor antagonists containing the conformationally constrained phenylalanine derivatives, including the new amino acid Xic.
Gibson SE; Guillo N; Jones JO; Buck IM; Kalindjian SB; Roberts S; Tozer MJ
Eur J Med Chem; 2002 May; 37(5):379-89. PubMed ID: 12008052
[TBL] [Abstract][Full Text] [Related]
40. Diastereomeric separation of 1,5-benzodiazepines due to the presence of a chiral centre on the N-5 alkylic chain.
Araldi GL; Donati D; Tranquillini ME; Ursini A
Farmaco; 1998 Jan; 53(1):49-54. PubMed ID: 9543726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
